Skip to Main Content
Phase I-II

A Phase 1/2a Study of Bria-PROS+ Cellular Immunotherapy in Metastatic Prostate Cancer

  • Study IRB#:2000043724
  • Last Updated:11/16/2026

To evaluate the safety of Bria-PROS+ cellular immunotherapy in patients with advanced prostate cancer

    Contact Us

    For more information about this study, including how to volunteer, contact:

    Jialing Zhang

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877-978-8343 for more information.

    Study Location

    • Yale University

    Principal Investigator

    Sub-Investigators

    For more information about this study, including how to volunteer, contact: